Infections by Organism
Bacteria
Fungi
Parasites
Viruses
Bacteria
Lyme Disease
MRSA
Nervous System Lyme Disease
Nontuberculosis Mycobacterial (NTM) Diseases
Treatment of Tuberculosis (TB)
Control of Tuberculosis
International Standards or Care of Tuberculosis
Lyme Disease
“The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis”
Clinical Infectious Diseases 2006; 43:1089–134
Lyme disease is the most common tick-borne infection in both North America and Europe. In the United States, Lyme disease is caused by Borrelia burgdorferi, which is transmitted by the bite of the tick species Ixodes scapularis and Ixodes pacificus. Clinical manifestations most often involve the skin, joints, nervous system, and heart. more »
Lyme Disease 2000 Guideline (PDF)
MRSA
"Management of Patients with Infections Caused by Methicillin-Resistant Staphylococcus Aureus: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA)"
*Projected Publication, Fall 2010
Nervous System Lyme Disease
“Practice Parameter: Treatment of Nervous System Lyme Disease” (Endorsed by IDSA)
Neurology 2007; 69:91-102
Lyme disease is a multisystem infectious disease caused by the tick-borne spirochete Borrelia burgdorferi, which frequently affects the nervous system. Published guidelines are available to assist in the diagnosis of nervous system Lyme disease, and for treatment of Lyme disease in general. However, there continues to be considerable controversy and uncertainty about the best approach to treatment of neuroborreliosis.
Nontuberculous Mycobacterial (NTM) Diseases
“Diagnosis, Treatment and Prevention of Nontuberculous Mycobacterial Diseases”
American Journal of Respiratory Critical Care Medicine 2007; 175:367–416
The minimum evaluation of a patient suspected of nontuberculous mycobacterial (NTM) lung disease should include the following: (1) chest radiograph or, in the absence of cavitation, chest high-resolution computed tomography (HRCT) scan; (2) three or more sputum specimens for acid-fast bacilli (AFB) analysis; and (3) exclusion of other disorders, such as tuberculosis (TB). Clinical, radiographic, and microbiologic criteria are equally important and all must be met to make a diagnosis of NTM lung disease.
Treatment of Tuberculosis (TB)
“Practice Guidelines for the Treatment of Tuberculosis”
MMWR 2003; 52 (RR-11)
The overall goals for treatment of tuberculosis are (1) to cure the individual patient, and (2) to minimize the transmission of Mycobacterium tuberculosis to other persons. Thus, successful treatment of tuberculosis has benefits both for the individual patient and the community in which the patient resides... Prescribing physician responsibility for treatment completion is a fundamental principle in tuberculosis control.
TB 2000 Guideline (PDF)
Control of Tuberculosis (TB)
“Controlling Tuberculosis in the United States” (Endorsed by IDSA)
American Journal of Respiratory Critical Care Medicine 2005; 172:1169–227
During 1993–2003, incidence of tuberculosis (TB) in the United States decreased 44% and is now occurring at a historic low level (14,874 cases in 2003)... In this statement, the American Thoracic Society (ATS), Centers for Disease Control and Prevention (CDC), and the Infectious Diseases Society of America (IDSA) propose recommendations to improve the control and prevention of TB in the United States and to progress toward its elimination.
International Standards for Care of Tuberculosis
“International Standards for Tuberculosis Care” (Endorsed by IDSA)
World Health Organization, 2006
The purpose of the International Standards for Tuberculosis Care (ISTC) is to describe a widely accepted level of care that all practitioners, public and private, should seek to achieve in managing patients who have, or are suspected of having, tuberculosis. The Standards are intended to facilitate the effective engagement of all care providers in delivering high-quality care for patients of all ages, including those with sputum smear-positive, sputum smear-negative, and extra pulmonary tuberculosis, tuberculosis caused by drug-resistant Mycobacterium tuberculosis complex (M. tuberculosis) organisms, and tuberculosis combined with human immunodefi ciency virus (HIV) infection.
